Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity.

Akanji MA, Elijah OO, Oyedolapo AA, Aderonke AA, Opeoluwa OL, Omoloye AA, Oladoja FA, Olatundun SO, Edatomolaosi OL

Open source

DOI
10.1515/dmpt-2021-0166
Published
2022 Sep 1
Container
Drug metabolism and personalized therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/dmpt-2021-0166,
  title = {Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity.},
  author = {Akanji MA and Elijah OO and Oyedolapo AA and Aderonke AA and Opeoluwa OL and Omoloye AA and Oladoja FA and Olatundun SO and Edatomolaosi OL},
  year = {2022},
  journal = {Drug metabolism and personalized therapy},
  doi = {10.1515/dmpt-2021-0166},
  url = {https://doi.org/10.1515/dmpt-2021-0166}
}

RIS

TY  - JOUR
TI  - Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity.
AU  - Akanji MA
AU  - Elijah OO
AU  - Oyedolapo AA
AU  - Aderonke AA
AU  - Opeoluwa OL
AU  - Omoloye AA
AU  - Oladoja FA
AU  - Olatundun SO
AU  - Edatomolaosi OL
PY  - 2022
JO  - Drug metabolism and personalized therapy
DO  - 10.1515/dmpt-2021-0166
UR  - https://doi.org/10.1515/dmpt-2021-0166
ER  - 

APA

MA, A., OO, E., AA, O., AA, A., OL, O., AA, O., FA, O., SO, O., & OL, E. (2022). Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity.. Drug metabolism and personalized therapy. https://doi.org/10.1515/dmpt-2021-0166

Source records